Improving the efficacy of radiation treatment for cancers

Our work involves development of technologies and therapies to effectively control cancer while having low toxicity in normal tissues, via targeted therapies with decreased toxicity using radiolabeled antibodies and peptides; radioprotection via enzyme inhibitor drugs; radiosensitization of resistant cancer tissues using lipid receptor antagonists; and preventing or treating radiation-induced lymphopenia.

Latest news